Biopharma & Life Sciences: One of the Strongest Capital-Ready Segments Under the Fund
Biopharma & Life Sciences: Biopharma and life sciences manufacturing is structurally advantaged among all those sectors quietly entrained to the logic of the design of the ₹10,000 Cr Startup and ...












